Ebola crisis deepens in DR Congo as cases surge in hotspots
This outbreak, caused by the **Bundibugyo virus**, has become the second-largest Ebola outbreak ever recorded and the fastest-spreading in Congo’s history.
Search fresh public links, source activity, and ready-to-use post angles for Bundibugyo Virus.
Fresh curated links around Bundibugyo virus are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
This outbreak, caused by the **Bundibugyo virus**, has become the second-largest Ebola outbreak ever recorded and the fastest-spreading in Congo’s history.
[Nile Post] Researchers from the Interdisciplinary Consortium for Epidemic Research and Response (ICER) and collaborating institutions have identified a previously unreported varia...
Bundibugyo virus is a rare type of Ebola that has no approved vaccine or treatment.
The Bundibugyo Ebola virus takes its name from this small town, where it was first discovered in 2007. Now, the species has returned to eastern Congo, halting life on a busy border...
The virus is responsible for the escalating outbreak in the Democratic Republic of the Congo (DRC), which the World Health Organization (WHO) declared a public health emergency of...
BU virologist Nancy Sullivan says the Bundibugyo outbreak in the Democratic Republic of the Congo underscores the need for broader outbreak preparedness. The death of a nurse marke...
The first vaccine against the Bundibugyo ebola virus is poised to enter phase 1 clinical trial.
The deadly Bundibugyo virus disease (BVD) outbreak in the Democratic Republic of the Congo (DRC) has escalated sharply, with 4,665 confirmed cases and 2,184 deaths recorded as of A...
[Nile Post] The United States government has delivered an experimental antibody treatment for Ebola to Uganda's Ministry of Health, strengthening the country's preparedness amid an...
The Director-General (DG) of the World Health Organization (WHO) is hereby transmitting the report of the second meeting of the International Health Regulations (2005) ( IHR ) Eme...
The recent Ebola outbreak caused by the Bundibugyo strain of the virus has reportedly claimed more than 3,000 lives, and more than twice as many reported cases, in the Democratic R...
Agencies are on high alert amid reports that the rapidly spreading Ebola Bundibugyo virus species in the Democratic Republic of the Congo (DRC) has infected 19 internally displaced...
The deadly Bundibugyo ebolavirus strain currently has no licensed vaccine or specific treatments and is spreading faster than all previous Ebola outbreaks.
According to the Rospotrebnadzor, the test kit provides high sensitivity and specificity even in the early stages of infection
Glasgow scientists test existing Ebola vaccine against Bundibugyo - The Herald
Learn how a rare Ebola strain has fueled one of the largest outbreaks on record and what the first human vaccine trial could mean for containing the outbreak.
DRC receives 70,000 Ervebo vaccine doses, with 20,000 for a Phase III trial against Bundibugyo virus and 50,000 for frontline and health workers. The post Ebola: DRC gets 70,000 Er...
The early-stage trial will enroll 50 healthy adults to assess the vaccine's safety and immune response.
A volunteer was injected on Friday with the first dose of a rapidly developed vaccine targeting the Bundibugyo strain of Ebola driving a deadly outbreak in the Democratic Republic...
A vaccine trial is under way as part of efforts to tackle the Bundibugyo ebolavirus.
Scientists at the Oxford Vaccine Group (OVG) inoculated the first volunteer with a new vaccine against Bundibugyo ebolavirus (BDBV) on 24 July. The milestone comes after just weeks...
The East, Central and Southern Africa Health Community (ECSA-HC) has launched a six-month cross-border emergency intervention at 33 priority points of entry (PoEs) along the Democr...
The Phase I clinical trial, known as BD-Ebov, will evaluate the safety of the experimental vaccine and its ability to stimulate immune responses in healthy adult volunteers. The po...
The two new zones affected are Biena and Manguredjipa in Congo's North Kivu province, where the case fatality rate is much higher than the overall rate of 48%, due in part to delay...
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.